A Motion Exergaming Approach to Promote Self-Managing Fatigue and Pain after Head and Neck Cancer Treatment

运动游戏方法可促进头颈癌治疗后自我管理疲劳和疼痛

基本信息

  • 批准号:
    10618083
  • 负责人:
  • 金额:
    $ 59.3万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-12-13 至 2025-11-30
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract Among head and neck cancer (HNC) patients, 92% report fatigue and 73% have pain. A 10% increase in fatigue or pain is associated with a 10-25% reduction in HNC survival. During the critical transition period from the end of active treatment to 3 months post-treatment (during which patients begin symptom self- management), untreated physical symptoms negatively impact functional status (ADL) and quality of life (QOL). Fatigue and musculoskeletal pain (related to tissue damage from surgery and radiation) are known to improve in response to physical activity (PA). However, 51% of HNC survivors rarely engage in any type of PA because of complicated PA barriers: impaired fitness, severe physical symptoms, and poor PA health beliefs. A critical gap in our science is that no home-based behavioral PA intervention effectively addresses these PA barriers in HNC patients. To address this gap, our overall objective is to test an intervention to overcome these PA barriers for HNC patients during the critical transition period to self-management. PAfitME, a personalized Physical Activity intervention with fitness graded Motion Exergames, is a telehealth program built on Social Cognitive Theory and the exercise principal of adaptation. PAfitME is personalized to the HNC patient's PA barriers. PAfitME, delivered via a tested mix of FaceTime calls and home visits, uses commercially available exergaming platforms (Wii Fit and Xbox Kinect). Our pilot study generated impressive within-group effect sizes for fatigue, pain, and ADL (d≥0.9). The feasibility and acceptability of PAfitME were also strong in patients with several physical limitations. Attendance (98%) and attrition (20%) were much better than previous HNC studies without adverse events. We propose the following specific aims: (1) When compared to an attention control group, determine the effect of PAfitME on fatigue and musculoskeletal pain at week 6, when controlling for age and sex; (2) when compared to an attention control group, determine the effect of PAfitME on functional status and QOL at week 6, when controlling for age and sex; and (3) explore if PA self-efficacy, PA enjoyment, and exergame minutes mediate the effect of PAfitME on fatigue and musculoskeletal pain. This study will evaluate 150 post-treatment (radiation or chemoradiation) HNC patients in an RCT with an attention control. For 6 weeks, the experimental (PAfitME) group will receive the PAfitME intervention, and the attention control group will receive NCI-based survivorship education and exergame equipment (Wii Fit or Xbox Kinect without PAfitME). For Aims 1 and 2, using an ITT framework, we will fit a series of linear mixed effects models with each of the outcome variables. For Aim 3, we will conduct our exploratory analyses in ml_mediation (STATA 15), which will compute direct and indirect effects for multi-level data. This study aligns with the NCI Cancer Moonshot goal to minimize cancer treatment-associated side effects and the key recommendation in the National Comprehensive Cancer Network Clinical Guidelines of the need for evidence-based non- pharmacological fatigue/pain treatments (National Priority).
项目总结/摘要 在头颈癌(HNC)患者中,92%的人报告疲劳,73%的人有疼痛。增加10%的 疲劳或疼痛与HNC存活率降低10-25%有关。在关键的过渡时期, 活性治疗结束至治疗后3个月(在此期间,患者开始出现症状自 管理),未经治疗的身体症状对功能状态(ADL)和生活质量产生负面影响 (QOL)。已知疲劳和肌肉骨骼疼痛(与手术和辐射引起的组织损伤有关) 改善对体力活动(PA)的反应。然而,51%的HNC幸存者很少参与任何类型的PA 因为复杂的PA障碍:健康受损,严重的身体症状,以及PA健康信念差。 我们科学中的一个关键差距是,没有基于家庭的行为PA干预有效地解决这些PA HNC患者的障碍。为了解决这一差距,我们的总体目标是测试一种干预措施,以克服这些问题。 在自我管理的关键过渡期,HNC患者的PA障碍。PAfitME,个性化 体育活动干预与健身分级运动游戏,是一个远程保健计划建立在社会 认知理论与适应性锻炼原则。PAfitME针对HNC患者的PA进行个性化设置 隔栏. PAfitME通过FaceTime通话和家访的测试组合提供, 游戏平台(Wii Fit和Xbox Kinect)。我们的试点研究产生了令人印象深刻的组内效应量 疲劳、疼痛和ADL(d≥0.9)。PAfitME的可行性和可接受性也很强, 几个物理限制。出勤率(98%)和自然减员率(20%)比以前的HNC研究要好得多 无不良事件。我们提出以下具体目标:(1)与注意控制相比, 组,在控制年龄时,确定PAfitME对第6周疲劳和肌肉骨骼疼痛的影响 (2)与注意力控制组相比,确定PAfitME对功能状态的影响 和QOL在第6周,当控制年龄和性别;和(3)探讨是否PA自我效能,PA享受, 运动分钟介导PAfitME对疲劳和肌肉骨骼疼痛的作用。本研究将评估 一项RCT中的150例治疗后(放疗或放化疗)HNC患者,采用注意力控制。6个 实验组(PAfitME)接受PAfitME干预,注意力控制组 将接受基于NCI的生存教育和exergame设备(Wii Fit或Xbox Kinect,不带 PAfitME)。对于目标1和2,使用ITT框架,我们将拟合一系列线性混合效应模型, 每个结果变量。对于目标3,我们将在ml_mediation(STATA)中进行探索性分析 15),它将计算多水平数据的直接和间接影响。这项研究与NCI癌症 Moonshot的目标是最大限度地减少癌症治疗相关的副作用, 国家综合癌症网络临床指南的需要循证非 药物疲劳/疼痛治疗(国家优先)。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Hsiao-Lan Wang其他文献

Hsiao-Lan Wang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Hsiao-Lan Wang', 18)}}的其他基金

A Motion Exergaming Approach to Promote Self-Managing Fatigue and Pain after Head and Neck Cancer Treatment
运动游戏方法可促进头颈癌治疗后自我管理疲劳和疼痛
  • 批准号:
    10311089
  • 财政年份:
    2019
  • 资助金额:
    $ 59.3万
  • 项目类别:

相似海外基金

Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
  • 批准号:
    10707830
  • 财政年份:
    2023
  • 资助金额:
    $ 59.3万
  • 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
  • 批准号:
    479728
  • 财政年份:
    2023
  • 资助金额:
    $ 59.3万
  • 项目类别:
    Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
  • 批准号:
    10884567
  • 财政年份:
    2023
  • 资助金额:
    $ 59.3万
  • 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
  • 批准号:
    10751964
  • 财政年份:
    2023
  • 资助金额:
    $ 59.3万
  • 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
  • 批准号:
    486321
  • 财政年份:
    2022
  • 资助金额:
    $ 59.3万
  • 项目类别:
    Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
  • 批准号:
    10676786
  • 财政年份:
    2022
  • 资助金额:
    $ 59.3万
  • 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
  • 批准号:
    10440970
  • 财政年份:
    2022
  • 资助金额:
    $ 59.3万
  • 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
  • 批准号:
    10642998
  • 财政年份:
    2022
  • 资助金额:
    $ 59.3万
  • 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
  • 批准号:
    10482465
  • 财政年份:
    2022
  • 资助金额:
    $ 59.3万
  • 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
  • 批准号:
    10191053
  • 财政年份:
    2020
  • 资助金额:
    $ 59.3万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了